Ovarian Cancer Plaintiffs Push Back On J&J Challenges To $4.69B Asbestos Award
ST. LOUIS — A $4.69 billion asbestos-talc ovarian cancer verdict was not the prejudicial mess of improperly admitted experts, misapplied standards and a confused jury portrayed by Johnson & Johnson, plaintiffs...To view the full article, register now.
Already a subscriber? Click here to view full article